Literature DB >> 9614499

Single-channel properties of L-type calcium channels from failing human ventricle.

R Handrock1, F Schröder, S Hirt, A Haverich, C Mittmann, S Herzig.   

Abstract

OBJECTIVE: The aim of our study was to analyse the single-channel properties of L-type calcium channels from failing human heart and to compare them to the respective animal data. Furthermore, we intended to evaluate the feasibility of future single-channel studies on the role of calcium channels in the pathophysiology of heart failure.
METHODS: Single L-type calcium channels were recorded in ventricular myocytes from explanted failing human heart, using the cell-attached configuration of the patch-clamp technique.
RESULTS: One or more successful registrations of calcium channels could be obtained in 11 of 19 cell isolations. Determination of single-channel conductance yielded a mean value of 16.6 +/- 1.2 pS (70 mM Ba2+ as the charge carrier) under control conditions and 23.7 +/- 2.8 pS in presence of the calcium-channel agonist FPL 64176. The rapid gating process could be described by a C<-->C<-->O gating scheme. Slow gating analysis revealed a highly significant clustering of active and non-active sweeps.
CONCLUSION: Single-channel measurements of L-type calcium channels in human failing ventricle are feasible and reproducible despite the varying patient characteristics. Their channel properties are qualitatively comparable to those found in other mammals. Whether there are quantitative differences due to the underlying heart failure can be elucidated in further studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614499     DOI: 10.1016/s0008-6363(97)00257-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

1.  Effects of FPL 64176 on Ca transients in voltage-clamped rat ventricular myocytes.

Authors:  Jing-Song Fan; Philip Palade
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Ion concentration-dependence of rat cardiac unitary L-type calcium channel conductance.

Authors:  A Guia; M D Stern; E G Lakatta; I R Josephson
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

3.  Mechanisms of excitation-contraction coupling in an integrative model of the cardiac ventricular myocyte.

Authors:  Joseph L Greenstein; Robert Hinch; Raimond L Winslow
Journal:  Biophys J       Date:  2005-10-07       Impact factor: 4.033

4.  FPL 64176 modification of Ca(V)1.2 L-type calcium channels: dissociation of effects on ionic current and gating current.

Authors:  Stefan I McDonough; Yasuo Mori; Bruce P Bean
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

5.  The role of stochastic and modal gating of cardiac L-type Ca2+ channels on early after-depolarizations.

Authors:  Antti J Tanskanen; Joseph L Greenstein; Brian O'Rourke; Raimond L Winslow
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

Review 6.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

7.  Nanodomain control of exocytosis is responsible for the signaling capability of a retinal ribbon synapse.

Authors:  Tim Jarsky; Miao Tian; Joshua H Singer
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

8.  Modeling the actions of beta-adrenergic signaling on excitation--contraction coupling processes.

Authors:  Joseph L Greenstein; Antti J Tanskanen; Raimond L Winslow
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

9.  An integrative model of the cardiac ventricular myocyte incorporating local control of Ca2+ release.

Authors:  Joseph L Greenstein; Raimond L Winslow
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

10.  A simplified local control model of calcium-induced calcium release in cardiac ventricular myocytes.

Authors:  R Hinch; J L Greenstein; A J Tanskanen; L Xu; R L Winslow
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.